Cellectis (CLLS) Asset Utilization Ratio (2015 - 2026)
Cellectis' (CLLS) Asset Utilization Ratio stood at 0.21 in Q2 2026, up 35.0% from 0.16 a year earlier but down 7.7% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Starting with Q4 2015, Cellectis' Asset Utilization Ratio history includes 43 quarters.
- Across earlier years, Asset Utilization Ratio came in at 0.12 in FY2024, 0.00 in FY2023 (-95.7%), 0.06 in FY2022 (-16.4%) and 0.07 in FY2021 (+45.9%).
- Quarterly Asset Utilization Ratio has ranged from 0.00 in Q4 2023 to 0.23 in Q1 2026 over the past five years.
- On a year-over-year basis, Asset Utilization Ratio has increased for six consecutive quarters, with growth averaging 218.9% over the last seven quarters.
- Peak year-over-year performance for Asset Utilization Ratio in the last five years was growth of 753.0% in Q1 2025, against a decline of 96.1% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.23 (Q1 2026), 0.23 (Q4 2025) and 0.22 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.31 |
| 10 | Cellectis | 111.38 Mn | -642.02 Mn | - | 0.21 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.21 |
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | 0.23 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.13 |
| Dec 31, 2024 | 0.11 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.07 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.14 |
| Sep 30, 2021 | 0.13 |
API Access
Cellectis Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();